Claude's syndrome is a rare midbrain stroke syndrome characterized by ipsilateral third cranial nerve (oculomotor) palsy and contralateral hemiataxia, resulting from a lesion involving the superior cerebellar peduncle (SCP) and adjacent oculomotor nerve fascicles in the ventromedial midbrain. [1-3] Named after the French neurologist Henri Claude, it is among the classic crossed brainstem syndromes, though in clinical practice it is exceedingly rare — a prospective study of 308 brainstem stroke patients identified only 1 case of Claude's syndrome. [4]
1. History
- Acute onset of diplopia, ptosis, and gait unsteadiness or limb incoordination
- Timing: typically sudden (stroke) but can be subacute (tumor, infection, demyelination)
- Ask about headache, vertigo, nausea, dysarthria, visual changes
- Prior TIA symptoms, neck pain or trauma (dissection), recent procedures
- Vascular risk factors: hypertension, diabetes, smoking, atrial fibrillation, hyperlipidemia
- History of malignancy, TB exposure, immunosuppression (for non-vascular etiologies) [1][5]
2. Alarm Features
- Acute onset with progressive neurological deficits → concern for basilar artery occlusion or expanding hemorrhage
- Altered consciousness, bilateral motor deficits → brainstem compression or bilateral infarction
- Concurrent hemiparesis → suggests extension into cerebral peduncle (overlap with Weber or Benedikt syndrome)
- Neck pain with acute onset → vertebral or basilar artery dissection
- Fever, meningismus → infectious etiology (e.g., neurocysticercosis, abscess) [5]
3. Medications
- Acute ischemic stroke: IV alteplase (within 4.5 hours) or mechanical thrombectomy if large vessel occlusion [6]
- Antiplatelet therapy: aspirin ± clopidogrel for secondary prevention; one case report documented resolution of Claude's syndrome within 10 days with antiplatelet therapy alone [7]
- Anticoagulation: if cardioembolic source or vertebrobasilar dissection
- Steroids + albendazole: if neurocysticercosis is the etiology [5]
- Steroids + immunosuppression: if neuro-Behçet disease or demyelination [1]
- Avoid anticoagulants if hemorrhagic etiology is suspected until imaging confirms ischemic stroke
4. Diet
- Standard stroke dietary recommendations: low-sodium, heart-healthy diet
- Dysphagia screening prior to oral intake (brainstem strokes carry aspiration risk)
- Adequate hydration; NPO if swallowing is compromised
5. Review of Systems
- Neuro: diplopia, ptosis, blurred vision, gait instability, limb weakness, numbness, dysarthria, dysphagia, vertigo
- Cardiovascular: palpitations (atrial fibrillation), chest pain
- Head/Neck: headache, neck pain (dissection), facial pain
- Constitutional: fever, weight loss (malignancy, TB, infection)
- Rheumatologic: oral/genital ulcers, skin lesions (Behçet disease) [1]
- Ophthalmologic: visual field deficits, pupillary changes
6. Collateral History and Family History
- Witnesses to symptom onset and time of last known well (critical for thrombolysis window)
- Functional baseline and prior neurological deficits
- Family history of stroke, coagulopathy, connective tissue disorders, vasculitis
- Social history: smoking, alcohol, illicit drug use (cocaine, amphetamines)
- Travel history if infectious etiology considered (neurocysticercosis endemic areas) [5]
7. Risk Factors
- Hypertension — the most common associated risk factor; small vessel disease is a leading etiology [2][8]
- Diabetes mellitus, hyperlipidemia, smoking
- Atrial fibrillation or other cardioembolic sources
- Vertebrobasilar hypoplasia — found in up to 77.7% of isolated midbrain infarction patients [8]
- Basilar artery stenosis or large vessel disease [9]
- Vasculitis (Behçet disease, CNS vasculitis) [1]
- Hypercoagulable states
8. Differential Diagnosis
The key differentials are other midbrain stroke syndromes, distinguished by the structures involved:
Other important differentials:
- Isolated CN III palsy (microvascular, aneurysmal) — no ataxia; pupil involvement suggests compressive lesion (PCA aneurysm)
- Cerebellar stroke — ataxia without CN III palsy
- Midbrain mass lesion (tumor, abscess, tuberculoma, neurocysticercosis) — subacute onset, may have ring enhancement on MRI [5][10]
- Demyelination (MS) — younger patients, relapsing-remitting course
- "Reverse Claude's syndrome" — ipsilateral (rather than contralateral) ataxia with CN III palsy, from lesion at the rostral SCP decussation [11]
9. Past Medical History
- Prior stroke or TIA
- Hypertension, diabetes, coronary artery disease, atrial fibrillation
- Known vertebrobasilar disease or posterior circulation anomalies
- Malignancy (metastatic disease to midbrain)
- Autoimmune/inflammatory conditions (Behçet, sarcoidosis, MS)
- Prior head/neck surgery or procedures
10. Physical Exam
Vital signs: Blood pressure (hypertension or hypotension), heart rate/rhythm (irregular → AF), oxygen saturation
Focused neurological exam
- Ipsilateral CN III palsy: ptosis, "down and out" eye position, impaired adduction/elevation/depression; pupil may be spared (partial/fascicular palsy is common) [3][7][12]
- Contralateral hemiataxia: finger-to-nose dysmetria, heel-to-shin ataxia, gait ataxia on the side opposite the CN III palsy
- Truncal ataxia: may be subtle — assess with tandem gait, which may be the only revealing maneuver [12]
- Absence of contralateral hemiparesis (distinguishes from Weber's syndrome)
- Absence of contralateral tremor (distinguishes from Benedikt's syndrome, though overlap exists)
- Assess for vertical gaze palsy, internuclear ophthalmoplegia, nystagmus
- Full cranial nerve exam, motor strength, sensory exam, reflexes
11. Lab Studies
- CBC, BMP, coagulation studies (PT/INR, aPTT)
- Glucose (hypo/hyperglycemia as stroke mimic)
- Lipid panel, HbA1c
- ESR/CRP if vasculitis or inflammatory etiology suspected
- Hypercoagulability workup in young patients without traditional risk factors
- Blood cultures, RPR/VDRL if infectious etiology considered
- CSF analysis if neurocysticercosis, neuro-Behçet, or demyelination suspected (cell count, protein, glucose, cytology, cysticercosis antibodies, oligoclonal bands) [1][5]
12. Imaging
- Brain MRI with DWI — gold standard for midbrain infarction; demonstrates restricted diffusion in the ventromedial midbrain involving the SCP and oculomotor fascicles [2-3]
- MRA or CTA of head and neck — evaluate for basilar artery stenosis, vertebral artery hypoplasia, or dissection [8-9]
- Diffusion tensor imaging (DTI) — can delineate specific tract involvement (SCP decussation, tectospinal tract) in variant presentations [12]
- Contrast-enhanced MRI — if mass lesion, abscess, or neurocysticercosis suspected (ring enhancement, cystic lesion) [5]
- Echocardiography (TTE ± TEE) — evaluate for cardioembolic source [9]
13. Special Tests
- NIHSS — for stroke severity quantification and treatment eligibility
- Modified Rankin Scale (mRS) — baseline and follow-up functional assessment [8]
- Pharmacologic pupil testing — if Horner syndrome is also suspected (apraclonidine, cocaine test)
- Cerebral angiography — if vasculitis or aneurysm suspected and noninvasive imaging inconclusive
- Holter monitor / telemetry — to detect paroxysmal atrial fibrillation
14. ECG
- Obtain 12-lead ECG on all stroke presentations
- Evaluate for atrial fibrillation/flutter (cardioembolic source)
- ST-segment changes (concurrent MI or stress cardiomyopathy)
- QTc prolongation (baseline before initiating certain medications)
15. Assessment
Claude's syndrome is a rare but clinically localizing midbrain syndrome. In a prospective cohort of 308 brainstem stroke patients, classical crossed brainstem syndromes other than Wallenberg's were uncommon, with only 1 patient meeting criteria for Claude's syndrome. [4] The most common etiology is cerebrovascular disease (small vessel disease and large vessel disease), followed by malignancy. [2][5][9] Rare causes include neurocysticercosis, neuro-Behçet disease, and demyelination. [1][5]
Key clinical pearl: partial oculomotor nerve palsy (often pupil-sparing) is common, and limb ataxia may be subtle or absent — truncal ataxia revealed only by tandem gait testing may be the sole cerebellar sign. [12] This can lead to misdiagnosis as isolated CN III palsy if the exam is not thorough.
16. Treatment Plan
Acute management (ischemic etiology)
- Activate stroke protocol; determine time of last known well
- IV alteplase within 4.5 hours of symptom onset if eligible [6]
- Mechanical thrombectomy if basilar artery occlusion identified (per institutional protocol)
- Admit to stroke unit or ICU; continuous cardiac monitoring, neuro checks q1–2h
- Blood pressure management per AHA/ASA guidelines
- Glycemic control, normothermia, euvolemia
Secondary prevention
- Antiplatelet therapy (aspirin ± clopidogrel for 21 days, then monotherapy) for non-cardioembolic stroke
- Anticoagulation for cardioembolic source or dissection
- Statin therapy (high-intensity)
- Aggressive vascular risk factor management
Non-vascular etiologies
- Neurocysticercosis: albendazole + dexamethasone [5]
- Neuro-Behçet: corticosteroids ± immunosuppressants [1]
- Tumor: neurosurgical and oncology consultation
- Demyelination: IV methylprednisolone, disease-modifying therapy
Rehabilitation: early physical therapy, occupational therapy; ophthalmology for persistent diplopia (prism glasses, patching)
17. Disposition
- Admit all acute presentations for stroke workup, monitoring, and secondary prevention initiation
- ICU admission if: fluctuating deficits, basilar artery involvement, large infarct, or need for IV thrombolysis monitoring
- Observation may be appropriate for stable, minor deficits with completed workup
- Neurology consultation — all cases
- Neurosurgery consultation — if mass lesion, hemorrhage, or hydrocephalus
- Ophthalmology — for persistent oculomotor palsy management
- Prognosis is generally favorable for isolated midbrain infarction: 77.7% of patients had good functional outcomes (mRS ≤2) at 3-month follow-up; one case resolved completely within 10 days with antiplatelet therapy [7-8]
18. Follow Up / Return Precautions
- Neurology follow-up within 1–2 weeks post-discharge
- Ophthalmology follow-up for persistent diplopia or ptosis
- Primary care within 1 week for vascular risk factor optimization
- Return precautions: new or worsening weakness, vision changes, severe headache, difficulty speaking or swallowing, altered consciousness, gait worsening
- Expected course: many patients improve significantly; partial CN III palsy and ataxia may resolve over weeks to months [7-8]
- Long-term: medication adherence (antiplatelet/anticoagulant, statin), lifestyle modifications, stroke recurrence prevention
References
1. Claude Syndrome in Childhood Associated With Probable Neuro-Behcet Disease. — Yavuz P, Solmaz I, Kaya UA, et al. Neuropediatrics. 2023.
2. The Clinical and MRI Correlate of Ischaemia in the Ventromedial Midbrain: Claude's Syndrome. — Broadley SA, Taylor J, Waddy HM, Thompson PD. Journal of Neurology. 2001.
3. Localization of Claude's Syndrome. — Seo SW, Heo JH, Lee KY, et al. Neurology. 2001.
4. Classical Crossed Brain Stem Syndromes: Myth or Reality?. — Marx JJ, Thömke F. Journal of Neurology. 2009.
5. Claude's Syndrome Associated With Neurocysticercosis. — Song TJ, Suh SH, Cho H, Lee KY. Yonsei Medical Journal. 2010.
6. Management of Acute Ischemic Stroke. — Rigual R, Fuentes B, Díez-Tejedor E. Medicina Clinica. 2023.
7. Claude's Syndrome Without Ptosis Caused by a Midbrain Infarction. — Tsuda H, Fujita T, Maruyama K, Ishihara M. Internal Medicine. 2015.
8. Pure Midbrain Ischemia and Hypoplastic Vertebrobasilar Circulation. — Gilberti N, Gamba M, Costa A, et al. Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology. 2014.
9. Pure Midbrain Infarction: Clinical Syndromes, MRI, and Etiologic Patterns. — Bogousslavsky J, Maeder P, Regli F, Meuli R. Neurology. 1994.
10. Weber Syndrome Secondary to Brain Stem Tuberculoma. — Parija S, Lalitha CS, Naik S. Indian Journal of Ophthalmology. 2018.
11. Pupil-Sparing Third Nerve Palsies and Hemiataxia: Claude's and Reverse Claude's Syndrome. — Bateman JR, Murty P, Forbes M, et al. Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia. 2016.
12. Pitfalls in the Diagnosis of Pupil-Sparing Oculomotor Nerve Palsy Without Limb Ataxia: A Case Report of a Variant of Claude's Syndrome and Neuroanatomical Analysis Using Diffusion-Tensor Imaging. — Amano E, Komatuzaki T, Ishido H, et al. Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia. 2018.